Zinger Brief
- The acquisition of BRC Saude Mental & Terapias Assistidas Ltda. provides Bienstar access to the Brazilian market, the largest in Latin America, with a population of 215 million.
- Ketamine and ibogaine substances are regulated for medical use in Brazil.
- BRC conducts legal ibogaine and ketamine treatments in Brazil and operates under the Medical Directorship of Dr. Rasmussen, who has 27 years of experience and has treated more than 2,500 patients with psychedelic substances.
The Details
According to information procured exclusively by Benzinga, Bienstar Wellness Corp., an integrative mental health company with core operations in Latin America specializing in psychedelic medicine, has completed the acquisition of 100% of BRC Saude Mental E Terapias Assistidas Ltda. (BRC) a Brazilian company focused on ibogaine treatments for substance abuse.
The terms of the deal were not disclosed.
Marco Algorta, Bienstar's co-founder and CEO stated, "We are very excited with the completion of this acquisition which represents the company kick off in Brazil by starting to treat our first patients with Psychedelic-Assisted Psychotherapy in the country through our subsidiary BRC Saude Mental E Terapias Assistidas Ltda."
What Is Bienstar Wellness?
Bienstar Wellness Corp. is a company focused on bringing alternative mental health treatments to Latin America.
The company will provide psychedelic-assisted psychotherapy with approved substances, through a network of clinics across the region, including Brazil, Mexico, Perú, Uruguay and Panama where it will start treating patients with depression, mood disorders and substance abuse, affecting over 16.3 million people in Brazil.
Last year, Novamind Inc. NVMDF — now owned by Numinus NUMIF — announced a strategic investment and advisory agreement with Bienstar Wellness to assist in the expansion of Latin America's first network of integrative mental health clinics treating patients with psychedelic therapies.
Photo: Cottonbro, Pexels. Edited by Plastiboy.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.